These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11220351)

  • 1. Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.
    Katovich MJ; Pachori A
    Diabetes Obes Metab; 2000 Jan; 2(1):3-14. PubMed ID: 11220351
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue angiotensin generation and regulation of vascular tone.
    Cockcroft JR; O'Kane KP; Webb DJ
    Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system in cardiovascular disease.
    Cohn JN
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):341-4. PubMed ID: 20454841
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the renin-angiotensin system in the development of cardiovascular disease.
    Unger T
    Am J Cardiol; 2002 Jan; 89(2A):3A-9A; discussion 10A. PubMed ID: 11835903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
    Huber K; Pachinger O; Pichler M; Klein W
    Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system and its receptors.
    Stroth U; Unger T
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S21-8; discussion S41-3. PubMed ID: 10028950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin and insulin resistance: conspiracy theory.
    Townsend RR
    Curr Hypertens Rep; 2003 Apr; 5(2):110-6. PubMed ID: 12642009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renin-angiotensin system and vascular remodelling].
    Michel JB
    Med Sci (Paris); 2004 Apr; 20(4):409-13. PubMed ID: 15124112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of angiotensin in the metabolic syndrome and cardiovascular complications].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2002 Oct; 60(10):1898-903. PubMed ID: 12397681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
    Shimamoto K; Miura T
    Intern Med; 2007; 46(16):1303-4. PubMed ID: 17704610
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of angiotensin II receptors in the pathogenesis of cardiovascular diseases].
    Lehtonen J
    Duodecim; 1999; 115(13):1395-400. PubMed ID: 11912625
    [No Abstract]   [Full Text] [Related]  

  • 14. Signaling crosstalk angiotensin II receptor subtypes and insulin.
    Horiuchi M; Mogi M; Iwai M
    Endocr J; 2006 Feb; 53(1):1-5. PubMed ID: 16543666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II-sympathetic nervous system connection.
    van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Aug; 21(8):1453-4. PubMed ID: 12872035
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data.
    Brooks DP; Ohlstein EH; Ruffolo RR
    Am Heart J; 1999 Sep; 138(3 Pt 2):246-51. PubMed ID: 10467220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Concluding comment.
    Weber MA
    Am J Cardiol; 2001 Apr; 87(8A):44C. PubMed ID: 11334768
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of sodium depletion on the role of AT1- and alpha-adrenergic receptors in the regulation of forearm vascular tone in humans.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    J Hypertens; 1999 Feb; 17(2):229-35. PubMed ID: 10067792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.